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>20%). Baseline GLS also demonstrated the strongest 
diagnostic performance in predicting adverse LV remod-
elling (AUC = 0.79; 95% CI 0.60–0.98; p = 0.03). Post-
reperfused STEMI, baseline GLS was most closely associ-
ated with the presence of MVO or IMH. Baseline GLS was 
more strongly associated with adverse LV remodelling than 
other CMR parameters.
Keywords Haemorrhage · Cardiovascular magnetic 
resonance · Myocardial infarction · Left ventricular 
function
Abbreviations
AAR  Area at risk
AMI  Acute myocardial infarction
AUC  Area under the curve
CMR  Cardiovascular magnetic resonance
EF  Ejection fraction
FT  Feature tracking
GCS  Peak global circumferential strain
GCSR  Peak global circumferential strain rate
GLS  Peak global longitudinal strain
GLSR  Peak global longitudinal strain rate
GRS  Peak global radial strain
GRSR  Peak global radial strain rate
IMH  Intramyocardial haemorrhage
LGE  Late gadolinium enhancement
LV  Left ventricle
LVEDVi  Left ventricular end diastolic volume indexed
LVESVi  Left ventricular end systolic volume indexed
MR  Magnetic resonance
MVO  Microvascular obstruction
PCI  Percutaneous coronary intervention
RF  Radiofrequency
ROC  Receiver operator characteristics
Abstract In the setting of acute ST-elevation myocardial 
infarction (STEMI), it remains unclear which strain param-
eter most strongly correlates with microvascular obstruc-
tion (MVO) or intramyocardial haemorrhage (IMH). We 
aimed to investigate the association of MVO, IMH and 
convalescent left ventricular (LV) remodelling with strain 
parameters measured with cardiovascular magnetic reso-
nance (CMR). Forty-three patients with reperfused STEMI 
and 10 age and gender matched healthy controls under-
went CMR within 3-days and at 3-months following rep-
erfused STEMI. Cine, T2-weighted, T2*-imaging and late 
gadolinium enhancement (LGE) imaging were performed. 
Infarct size, MVO and IMH were quantified. Peak global 
longitudinal strain (GLS), global radial strain (GRS), 
global circumferential strain (GCS) and their strain rates 
were derived by feature tracking analysis of LV short-
axis, 4-chamber and 2-chamber cines. All 43 patients and 
ten controls completed the baseline scan and 34 patients 
completed 3-month scans. In multivariate regression, GLS 
demonstrated the strongest association with MVO or IMH 
(beta = 0.53, p < 0.001). The optimal cut-off value for GLS 
was −13.7% for the detection of MVO or IMH (sensitiv-
ity 76% and specificity 77.8%). At follow up, 17% (n = 6) 
of patients had adverse LV remodeling (defined as an abso-
lute increase of LV end-diastolic/end-systolic volumes 
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SD  Standard deviation
STEMI  ST-elevation myocardial infarction
T2*  T2-star-weighted imaging
T2W  T2-weighted imaging
Introduction
Microvascular obstruction (MVO) and intra-myocardial 
haemorrhage (IMH) as detected by cardiovascular mag-
netic resonance (CMR) are established independent adverse 
prognostic markers following reperfused ST-elevation myo-
cardial infarction (STEMI). The presence of MVO has been 
associated with ‘no re-flow’ on coronary angiography after 
revascularisation [1]. IMH is invariably associated with 
MVO and is caused by endothelial dysfunction following 
prolonged ischaemia/reperfusion injury with disruption of 
inter-endothelial junctions and extravasation of erythro-
cytes [2].
Myocardial systolic function after STEMI is convention-
ally assessed by calculating left ventricular ejection frac-
tion (EF) from left ventricular volumes [3–5]. However, 
global EF is load-dependent and neglects regional func-
tion [6]. Myocardial deformation may be a more accurate 
parameter of LV function, but its assessment is more chal-
lenging, due in part to the complex spatial orientation and 
distribution of muscle fibres in the longitudinal and circum-
ferential direction [7]. Emerging technologies have made it 
possible to study myocardial deformation by CMR using 
myocardial tagging and feature tracking (FT) derived strain 
[8, 9]. Strain (S) and strain rate (SR) are already established 
as more accurate measures of both regional and the global 
left ventricular function when compared to ejection frac-
tion and allow quantitative assessment of myocardial defor-
mation [10]. From strain analysis, several parameters can 
be derived and it is currently not known which of these, if 
any, are associated with the presence of MVO, IMH and 
adverse LV remodelling.
This study aimed to investigate the association of FT 
derived peak global longitudinal strain (GLS), peak global 
circumferential strain (GCS), peak global radial strain 
(GRS), peak global longitudinal strain rate (GLSR), peak 
global circumferential strain rate (GCSR) and peak global 
radial strain rate (GRSR) with the presence of MVO, IMH 
and adverse LV remodelling in acute reperfused STEMI.
Methods
Study population
Fifty-three subjects were prospectively recruited from a 
single large UK tertiary centre. They included forty-three 
patients with acute STEMI and ten age and sex matched 
healthy volunteers serving as controls (Fig. 1). The inclu-
sion criteria for STEMI patients were: first-time acute 
STEMI revascularized by primary percutaneous coronary 
intervention (PPCI) within 12  h of onset of chest pain. 
Fig. 1  Flow chart of the study 
cohort
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Acute STEMI was defined as per the current European 
Society of Cardiology (ESC) guidelines [11]. Exclusion 
criteria included: previous MI or coronary artery bypass 
grafting, cardiomyopathy, estimated glomerular filtration 
rate <30  ml/min/1.73  m2, haemodynamic instability (Kil-
lip class III/IV requiring on-going intravenous therapy 
[12]) and contraindication to CMR imaging. After PPCI, 
all patients were considered for ESC guideline approved 
post-myocardial infarction secondary prevention therapy at 
the discretion of the treating physician, and were enrolled 
in a cardiac rehabilitation programme if they were deemed 
suitable [11]. Healthy volunteers had no history or symp-
toms of cardiovascular disease, were on no cardiovascular 
or other relevant medication and had no contraindications 
to CMR.
Ethics approval
The study protocol was approved by the National Research 
Ethics Service (12/YH/0169) and complied with the Dec-
laration of Helsinki and all patients gave written informed 
consent.
Cardiac catheterization
Coronary angiography and revascularisation were per-
formed in a standard fashion as per current best practice 
guidelines [13]. TIMI flow grades were assessed visually as 
described previously after coronary angioplasty [21].
CMR examination
All patients underwent CMR imaging at 3.0  T (Achieva 
TX, Philips Healthcare, Best, The Netherlands) within 3 
days (median 2 days) of their index presentation and were 
invited to attend a further CMR study at 3 months. CMR 
imaging used a dedicated 32-channel cardiac phased array 
receiver coil. Cine imaging was performed using a bal-
anced steady-state free precession (SSFP) pulse sequence 
with a spatial resolution of 1.6 × 2.0 × 10 mm and 40 phases 
per cardiac cycle. 4-chamber, 2-chamber and LV short axis 
stack cine imaging were acquired for strain analysis using 
the same spatial and temporal resolution.
T2 weighted (T2w) and T2* imaging were performed 
using the ‘3-of-5’ approach by acquiring the central 3 slices 
of 5 parallel short-axis slices spaced equally from mitral 
valve annulus to LV apical cap [14]. 0.1 mmol/kg gadolin-
ium-DTPA (gadopentetate dimeglumine; Magnevist, Bayer, 
Berlin, Germany) was administered using a power injec-
tor (Spectris, Solaris, PA). Late gadolinium enhancement 
(LGE) was performed in 10–12 short-axis slices 16–20 min 
after contrast administration using an inversion recovery-
prepared T1-weighted gradient echo-pulse sequence. For 
each pulse sequence, images with artefact were repeated 
until any artefact was removed or minimized. The highest 
quality images were used for analysis.
Image analysis
Cine, T2w, T2* and LGE images were evaluated offline 
using commercially available software (cvi42 v5.1, Circle 
Cardiovascular Imaging Inc., Calgary, Canada). Left ven-
tricular volumes and EF were analyzed from cine images 
using standard methods [15]. Infarct location was deter-
mined by LGE imaging, according to standard guidelines 
[16]. The presence and size of infarction and MVO were 
measured from LGE images. Infarcted myocardium was 
defined as an area of LGE ≥ 2 standard deviations (SD) 
above remote myocardium, and infarct volume estimation 
included any hypointense core. We used the 2SD method 
as there are prognostic data for the 2SD infarct size esti-
mation in similar populations [17], and for consistency 
with analysis of T2w images. MVO was defined visually 
as the hypointense core within the infarcted zone and plani-
metered manually. Volumes of infarct and MVO were cal-
culated from planimetered areas through the whole short-
axis LV LGE stack by the modified Simpson’s method. The 
presence and extent of intra-myocardial haemorrhage was 
assessed by combined analysis of T2w and T2* sequences 
[8]. On T2w images, areas with mean signal intensity less 
than 2 SD below the periphery of the area at risk (AAR) 
were considered to be haemorrhage [18]. On the T2* 
images, the presence of a dark core within the infarcted 
area by visual inspection of the images was used as con-
firmation of myocardial haemorrhage. Concordant results 
between T2w and T2* were needed to confirm haemor-
rhage. If there was inconsistency between them, agreement 
between two experts informed the results. Presence/absence 
of both MVO and IMH were scored in a binary manner.
Strain analysis
Strain analysis was performed in a semi-automated manner 
using Circle Cardiovascular Imaging Inc., Calgary, Canada 
cvi42 v5.1 (Fig.  2). The observer performing the strain 
analysis was blinded to the baseline CMR parameters and 
advanced tissue characterization. Left ventricular endo-
cardial and epicardial borders were manually contoured 
in end-diastole from both long-axis cines (4-chamber and 
2 chamber). Endocardial borders, epicardial borders and 
reference points at both RV insertion points (anterior/infe-
rior) were contoured manually for each slice at end-dias-
tole from the short axis LV cine stack. GLS and GLSR 
were derived from the long-axis images and GRS, GRSR, 
GCS and GCSR were derived from the short-axis LV cine 
stack using published methods [19, 20]. Peak GLS, peak 
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GLSR, GRS, peak GRSR, peak GCS and peak GCSR were 
quantified.
Follow‑up scans
Follow-up scans were planned at 3  months following the 
index event. Patients were divided into two groups based 
on the presence of LV remodelling. Adverse LV remodel-
ling was defined as an absolute increase of LV end-diastolic 
or end-systolic volumes >20% at 3 months follow-up [21–
23]. Analysis of all follow-up data was performed blinded 
to acute scans.
Statistical analysis
Statistical analysis was performed using IBM SPSS® 
Statistics 21.0. Continuous variables are expressed as 
mean ± SD. Normality for quantitative data was estab-
lished using the Kolmogorov-Smirnov test. Demographic 
comparisons were performed with an independent samples 
t-test. A repeated-measures analysis of variance (ANOVA) 
was performed on demographic and CMR parameters. 
Post-hoc univariate analysis was performed by using Tukey 
test [24]. Step-wise multivariate linear regression was used 
for parameters with statistical significance]from one-way 
analysis (p < 0.1). The accuracy of myocardial deforma-
tion parameters in predicting presence of MVO or IMH 
was examined using receiver-operator characteristic (ROC) 
curve analyses, using Medcalc (v15.8). All statistical tests 
were 2-tailed; p values < 0.05 were considered significant. 
To reduce transfer bias, baseline demographics and CMR 
parameters of the followed up patients were compared to 
patients who did not receive follow-up CMR by ANOVA.
Results
Forty-three acute STEMI patients met the inclusion criteria. 
Demographics of patients and ten healthy volunteers are 
shown in Table 1. Infarct characteristics on CMR are listed 
in Table 2. No gender and age based differences in charac-
teristics were present between patient groups (p > 0.1).
Baseline data
Left ventricular EF, left ventricular end-systolic vol-
ume (LVESV), GLS, GCS, GRS and GRSR were signifi-
cantly altered in infarct patients versus healthy volunteers 
(p < 0.001 for all parameters individually) (Fig. 3). Stroke 
volume was also reduced in the infarct subjects (p = 0.023 
versus controls). Among the 43 infarct patients, 25 patients 
(58%) had MVO and 24 patients (56%) had confirmed 
IMH. GRS was significantly lower in patients with MVO or 
IMH than those without (22.7 ± 7% vs. 29 ± 7%; p = 0.02). 
Fig. 2  Multi-parametric CMR examination of two patients with 
ST-elevation myocardial infarction. Case 1 (a–d): Anterior MI with-
out MVO. a Epicardial (green) and endocardial (red) contours on a 
4-chamber cine. b Voxel derived feature tracking (FT) of the myocar-
dium at end-systole. c Global longitudinal strain (GLS) curve dem-
onstrating a GLS of −16.5%. d LGE short-axis demonstrating infarct 
in anterior wall. Case 2 (e–h): e Demonstrates the contours and (f) 
shows the end-systolic FT-derived strain myocardial points in a case 
of lateral infarction with MVO. g Demonstrates a significantly lower 
GLS, −9%. h Demonstrates infarct and presence of MVO on LGE-
images
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Additionally, both GCS and GLS were significantly lower 
in patients with compared with those without MVO or 
IMH (GCS: −11.6 ± 3% vs. −15.6 ± 3%, p < 0.001, GLS: 
−11 ± 3% vs. −15.2 ± 3.3%, p < 0.001) (Fig. 3).
On linear regression analysis, using all the demograph-
ics and imaging variables including infarct size, GLS dem-
onstrated the strongest association with presence of MVO 
or IMH (beta = 0.53, p < 0.001) (Table  3). Additionally, 
GCS demonstrated stronger correlation to the volume of 
MVO than GLS (r = 0.57, p < 0.001 vs r = 0.46, p = 0.002) 
(Table 4). The area under the curve (AUC) for the diagnos-
tic performance of determining the presence of MVO or 
IMH by GLS was 0.82 (95% CI: 0.69–0.94; p < 0.001). The 
optimal cut-off value determined by Youden index for GLS 
was −13.7% for the presence of MVO or IMH (sensitivity 
76% and specificity 78%) [25].
Follow‑up data
Thirty-four of the 43 patients underwent 3 month follow up 
CMR; six patients declined further follow-up and in three 
patients the scan quality of cines on follow up was not suit-
able for FT analysis. Demographics parameters (age, gen-
der, hypertension, hypercholesterolaemia, smoking history, 
diabetes mellitus) and baseline CMR parameters (pres-
ence of MVO or IMH, LVEDVi, LVESVi and all strain 
parameters) were not significantly different in the nine 
patients who did not attend for follow-up scans compared 
with the overall study population (p > 0.1). All 34 follow 
up scans showed complete resolution of MVO and IMH. 
As compared to baseline, relative improvement in EF was 
19 ± 24.5%. Of all the baseline CMR parameters (LVEDVi, 
LVESVi, GLS, GCS, GRS, MVO, IMH), LVESVi (r = 0.99, 
Table 1  Study demographics
Data as mean ± SD or n(%) unless indicated
HV healthy volunteers, NA not-applicable, STEMI ST-elevation myocardial infarction
† p-value between first–second combined versus healthy volunteers
* p-value between first and second STEMI group





N 25 18 10 –
Age (years) 59 ± 12 57 ± 10 62 ± 9 0.86*/0.30†
Male 22 (88%) 14 (78%) 3 (30%) 0.69*/0.35†
Body mass index (kg/m2) 29 ± 3 27 ± 3 27 ± 5 0.03*/0.28†
Current smoker 14 (32%) 9 (21%) 0 0.90*
Hypertension 7 (16%) 4(9%) 0 0.88*
Hypercholesterolemia 8 (18%) 5 (12%) 0 0.94*
Diabetes mellitus 5 (12%) 1(2%) 0 0.30*
Pain to balloon time (min) 286 ± 211 376 ± 386 NA 0.33*
TIMI flow grade 0/1 pre-PCI 22 (51%) 17 (39%) NA 0.78*
TIMI flow grade 3 post PCI 23 (53%) 18 (42%) NA 0.28*
Peak troponin I >30,000 ng/L 14 (32%) 24 (56%) NA 0.17
Anterior infarct 12 (28%) 8 (18%) NA 0.82*
Inferior infarct 10 (23%) 7 (16%) NA 0.94*
Lateral infarct 3 (7%) 3 (7%) NA 0.67*
Table 2  Imaging parameters at baseline
Data as mean ± SD. LV measurements are indexed to body surface 
area; infarct volumes are unindexed
LV EDVi left ventricular end diastolic volume (indexed), LV ESVi left 
ventricular end systolic volume (indexed), GCS peak global circum-
ferential strain, GCSR peak global circumferential strain rate, GLS 
peak global longitudinal strain, GLSR peak global longitudinal strain 
rate, GRS peak global radial strain, GRSR peak global radial strain 
rate
Characteristic MI (n = 43) Healthy volun-
teers (n = 10)
P value
Ejection fraction (%) 48 ± 10 63 ± 4 <0.001
LV EDVi (ml/m2) 82 ± 16 78 ± 20 0.47
LV ESVi (ml/m2) 42 ± 12 28 ± 8 <0.001
LV stroke volume (ml) 40 ± 11 49 ± 12 0.023
LGE infarct volume (ml) 15 ± 12 NA NA
LGE MVO volume (ml) 3 ± 5 NA NA
GRS (%) 25 ± 8 38 ± 7 <0.001
GRSR (%/s) 164 ± 50 268 ± 125 <0.001
GCS (%) −13 ± 4 − 20 ± 2 <0.001
GCSR (%/s) −106 ± 132 − 107 ± 12 0.99
GLS (%) −13 ± 4 − 20 ± 2 <0.001
GLSR (%/s) −128 ± 314 − 88 ± 13 0.68
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p < 0.002) and GLS (r = 0.97, p < 0.006) demonstrated the 
strongest correlation with improvement in EF at follow-up 
scan. GCS (r = 0.95, p = 0.01) and GRS (r = 0.91, p = 0.02) 
also demonstrated good correlations with improvement in 
EF at follow-up.
Adverse LV Remodelling
Out of 34 patients with follow-up data, 6 (17%) patients 
demonstrated adverse left ventricular remodelling. From all 
CMR baseline parameters, GLS demonstrated the strongest 
diagnostic performance in predicting adverse LV remodel-
ling (AUC = 0.79; 95% CI 0.60–0.98; p = 0.03) (Table 5).
Discussion
The main findings of this study are as follows: first, myo-
cardial deformation imaging by CMR reliably detects 
changes in acute infarct patients versus healthy controls. 
Second, the presence of MVO or IMH in acute reperfused 
STEMI is most strongly associated with GLS. Third, GLS 
showed modest association with adverse LV remodelling.
Our data complement the results of several previous 
investigations of the role of CMR-derived strain imaging 
in reperfused STEMI patients [18, 26–28]. Kidambi et al. 
studied the role of myocardial deformation using tissue tag-
ging derived strain in an acute reperfused infarct population 
[18]. They demonstrated that regional functional recov-
ery is poor in myocardial segments with MVO and IMH. 
Wong et  al. demonstrated that circumferential strain (CS) 
using tissue tagging correlates better than circumferential 
strain rate with regional functional recovery [29]. Both of 
these studies used tissue tagging, which has a relatively 
low temporal resolution (<30 frames/s), potentially lim-
iting its accuracy, especially in patients with higher heart 
rates. Moreover, acquisition of tissue tagged images often 
requires long series of breath holds, and tag fading during 
diastole limits the assessment of myocardial relaxation. FT 
analysis of cine loops may overcome these limitations. A 
study by Khan et al. compared tissue tagging to FT-derived 
strain in 24 acute reperfused STEMI patients. FT-derived 
strain was quicker to analyse, tracked the myocardium bet-
ter, had better inter-observer variability and stronger corre-
lations with infarct and oedema [27].
In a study of 74 patients, Buss et al. demonstrated that 
FT-derived GCS is strongly associated with infarct size and 
trans-murality of scar on LGE imaging [28]. This study 
also demonstrated that FT-derived GCS was more accurate 
than GLS for predicting preserved LV function at follow-
up. Notably, this study did not evaluate LV remodelling, 
presence of MVO, presence of IMH or functional recovery 
of LV defined by improvement in EF. Additionally, in this 
Fig. 3  Multiple comparison bars of myocardial strain in the study 
population (whiskers: standard deviations; SD)
367Int J Cardiovasc Imaging (2017) 33:361–370 
1 3
study, the FT-derived strain analysis algorithm tracked only 
the endo-/epi-myocardium to compute strain, and did not 
track pixels within the myocardium [30]. Tracking pixels 
within the myocardium is important, especially in the set-
ting of acute reperfused infarct where each layer of myo-
cardium (endo-, mid- and epi-) is going through different 
pathophysiological processes.
Our study adds to the growing body of literature on 
the ability of CMR to quantify left ventricular deforma-
tion with FT. We have shown that FT-derived myocardial 
deformation parameters (GCS, GRS and GLS) are altered 
significantly in patients with MVO or IMH (p < 0.05). 
MVO and IMH affect predominantly the sub-endocar-
dium, where most of the longitudinal myocardial fibres are 
located. It is thus plausible that GLS is the strongest pre-
dictor of MVO and IMH as shown in our study. GLS also 
demonstrated modest diagnostic performance to predict 
adverse LV remodelling at follow-up more than any other 
deformation parameter. In this study, the volume of MVO 
and infarct size were more strongly associated with GCS 
than GLS (Table  4). These results are not unexpected as 
larger infarcts with MVO will involve more myocardium 
transmurally.
Role of echocardiography
It is acknowledged that strain examination is more read-
ily available by echocardiography than CMR. All modern 
echocardiographic systems come with strain packages [31, 
32]. Early changes of microvascular obstruction (MVO) 
after AMI have been demonstrated by contrast echocardi-
ography [33–35]. In patients with AMI, echocardiographic 
studies can be performed at the bedside and GLS assess-
ment may be used as a ‘gatekeeper’ for further advanced 
imaging, for example, multi-parametric tissue characteriza-
tion on CMR. Further studies are needed to explore how 
echocardiography derived strain parameters compare to 
CMR-FT derived strain.
Clinical implications
Our findings have possible clinical implications as FT-
strain analysis can be performed rapidly from standard cine 
CMR images and allows the detection of the functional 
effects of MVO and IMH without the need for additional 
CMR tissue characterisation techniques (T2W and T2*) 
and analysis methods. From our one-center experience, the 
time for total left ventricular strain analysis by CMR FT is 
approximately 7 min. As demonstrated, a cut off value of 
−13.7% for GLS detects MVO or IMH with a sensitivity of 
76% and specificity of 77.8%. GLS can potentially predict 
the presence of MVO or IMH early after PPCI for STEMI. 
MVO and IMH are independent histopathological and car-
diac imaging markers of adverse prognosis and we specu-
late that their early detection from routinely acquired CMR 
cines may help tailor appropriate pharmacological inter-
ventions or guide stem cell therapy. Patients with known 
allergy to gadolinium-based contrast agents or patients with 
end-stage renal failure may also benefit from this technique.
Study limitations
In this study, we excluded patients who were unstable 
post-PPCI (higher Killip class, not able to lie flat because 
of shortness of breath and use of invasive monitoring). 
These patients are more likely to represent a higher risk 
group with an adverse prognosis. In our study population, 
the majority of patients with MVO had IMH and only one 
patient with MVO had no IMH. Hence, the data on GCS 
for IMH detection should be interpreted with caution.
Table 3  Univariate and multivariate analysis of longitudinal param-
eters of LV function to CMR derived clinical and prognostic markers
EF ejection fraction, LVEDVi left ventricular end-diastolic volume 
indexed, LVESVi left ventricular end-systolic volume indexed, GCS 
peak global circumferential strain, GCSR peak global circumferential 
strain rate, GLS peak global longitudinal strain, GLSR peak global 
longitudinal strain rate, GRS peak global radial strain, GRSR peak 
global radial strain rate
*Significant p-value
**Most significant p-value in multivariate











 Diabetes mellitus 0.21 0.19
 Pain-balloon time −0.15 0.33
CMR parameters
 LVEDVi 0.09 0.57
 LVESVi 0.38 0.01* 0.17 0.26
 EF −0.50 0.001* −0.27 0.13
 GRS −0.39 0.01* −0.07 0.67
 Infarct size 0.50 0.001* 0.36 0.01*
 GCS 0.52 <0.001* 0.29 0.16




368 Int J Cardiovasc Imaging (2017) 33:361–370
1 3
Another important limitation of our study was that 9 of 
43 patients did not have follow-up CMR scans. This may 
have introduced transfer bias although the two groups 
were not different for demographic and standard CMR 
parameters.
In our study, at follow-up, only 6 (17%) patients had 
adverse LV remodelling and hence the demonstrated diag-
nostic performance of GLS to predict remodelling should 
be interpreted with caution.
In the present study, only global parameters of strain 
were investigated. Assessment of regional left ventricu-
lar strain parameters by CMR FT demonstrates regional 
variations and their clinical role remains very speculative 
[36].
Conclusions
Myocardial deformation changes adversely in patients with 
acute STEMI. Baseline GLS by FT-analysis of cine CMR 
is strongly associated with the presence of MVO or IMH 
and could be used as surrogate functional imaging marker 
of these acute myocardial pathological changes in patients 
with acute STEMI. Baseline GLS demonstrated stronger 
association with adverse LV remodelling than other CMR 
parameters.
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Table 4  Association of 
baseline CMR volumetric and 
strain parameters to size of 
microvascular obstruction
EF ejection fraction, GCS peak global circumferential strain, GCSR peak global circumferential strain rate, 
GLS peak global longitudinal strain, GLSR peak global longitudinal strain rate, GRS peak global radial 
strain, GRSR peak global radial strain rate, LVEDVi left ventricular end-diastolic volume indexed, LVESVi 
left ventricular end-systolic volume indexed; r Pearson correlation coefficient
Bold text represents most signifcant r value and it’s corresponding p-value
Location of infarct Infarct volume (%) Microvascular obstruc-
tion volume (%)
r p value r p value r p value
EF 0.29 0.06 −0.37 0.01 −0.37 0.02
LVEDVi −0.18 0.24 0.20 0.20 0.08 0.60
LVESVi −0.24 0.12 0.41 0.01 0.30 0.05
SVi 0.03 0.87 −0.19 0.23 −0.24 0.13
GRS 0.19 0.21 −0.32 0.03 −0.39 0.01
GRSR 0.04 0.79 −0.24 0.13 −0.13 0.41
GCS −0.18 0.25 0.54 <0.001 0.57 <0.001
GCSR 0.21 0.18 −0.01 0.94 − 0.30 0.06
GLS −0.33 0.03 0.34 0.02 0.46 0.002
GLSR 0.12 0.44 0.20 0.20 0.10 0.52
Table 5  Association of baseline CMR parameters to adverse LV 
remodelling at follow-up visit
AUC area under the curve, CI confidence interval, EF ejection frac-
tion, GCS peak global circumferential strain, GCSR peak global cir-
cumferential strain rate, GLS peak global longitudinal strain, GLSR 
peak global longitudinal strain rate, GRS peak global radial strain, 
GRSR peak global radial strain rate, LV left ventricle, LVEDVI left 
ventricular end-diastolic volume indexed, LVESVI left ventricular 
end-systolic volume indexed,r Pearson correlation coefficient
Adverse LV remodelling
LVEDVi AUC = 0.60; 95% CI 0.34–0.86; p = 0.44
LVESVi AUC = 0.60; 95% CI 0.32–0.87; p = 0.47
LV EF AUC = 0.26; 95% CI 0.00–0.52; p = 0.07
GLS AUC = 0.79; 95% CI 0.60–0.98; p = 0.03*
GLSR AUC = 0.68; 95% CI 0.42–0.95; p = 0.16
GRS AUC = 0.32; 95% CI 0.11–0.54; p = 0.18
GRSR AUC = 0.34; 95% CI 0.16–0.52; p = 0.22
GCS AUC = 0.71; 95% CI 0.48–0.87; p = 0.11
GCSR AUC = 0.57; 95% CI 0.35–0.78; p = 0.62
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